SIC
VRDN icon

SJS Investment Consulting’s Viridian Therapeutics VRDN Stock Holding History

SJS Investment Consulting’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02K Buy
+110
New +$1.77K ﹤0.01% 1773

Other funds holding VRDN

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

SJS Investment Consulting's VRDN Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Viridian Therapeutics (VRDN) in Q2 2026: 110 shares worth $2.02K. The stake represents ﹤0.01% of the portfolio and ranks #1773 among its holdings.

27 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • SJS Investment Consulting held 110 shares of Viridian Therapeutics worth $2.02K as of Q2 2026.
  • Viridian Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • Viridian Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1773 holding.
  • 27 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.